fda label semaglutide naion warning 2025 Ozempic Lawsuit – July 2026 Update The FDA sent a warning

After 30 days on the 3 mg dosage, increase the dosage to 7 mg once daily

Key Efficacy Comparison Year 1 Outcomes: For chronic weight management in adults without diabetes, tirzepatide 15 mg achieved a mean 22.5% total body weight reduction in SURMOUNT-1 (N Engl J Med, 2022), while semaglutide 2.4 mg delivered approximately 15% in the STEP program

Results When combined with healthy lifestyle changes, patients can see an average of 14.9% body weight loss

Doctors often recommend a daily low-dose aspirin (sometimes called baby aspirin) to people who have already had a heart attack or stroke, or those who are at high risk for one